Context

Finding an effective therapy for acute viral bronchiolitis continues to be a major priority for paediatricians. Despite repeated efforts to analyse the ever-growing literature in order to discern a significant therapeutic effect, we still lack consensus that anything actually works.1,–,3 Hartling and colleagues have contributed to this debate with a Herculean effort, bringing a newer methodology to the topic which has not been applied in the past and may further a consensus that epinephrine is the preferred agent for short-term management of acute viral bronchiolitis.